Literature DB >> 904971

Acid-base status in dietary treatment of phenylketonuria.

F Manz, H Schmidt, K Schärer, H Bickel.   

Abstract

Blood acid-base status, serum electrolytes, and urine pH were examined in 64 infants and children with phenylketonuria (PKU) treated with three different low phenylalanine protein hydrolyzates (Aponti, Cymogran, AlbumaidXP) and two synthetic amino acid mixtures (Aminogran, PAM). The formulas caused significant differences in acid-base status, serum potassium, and chloride, and in urine pH. In acid-base balance studies in two patients with PKU, Aponti, PAM, and two modifications of PAM (P2 + P3) were given. We observed a change from mild alkalosis to increasing metabolic acidosis from Aponti (serum bicarbonate 25,8 mval/liter) to P3 (24,0Y, P2 (19, 3) and PAM (17,0). Urine pH decreased and renal net acid excretion increased. In the formulas PAM, P2 and P3 differences in renal net acid excretion correlated with differences in chloride and sulfur contents of the diets and of the urines. New modifications of AlbumaidXP and of PAM, prepared according to our recommendations, showed normal renal net acid excretion (1 mEq/kg/24 hr) in a balance study performed in one patient with PKU and normal acid base status in 20 further patients.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 904971

Source DB:  PubMed          Journal:  Pediatr Res        ISSN: 0031-3998            Impact factor:   3.756


  9 in total

1.  Biochemical and nutritional status of children with hyperphenylalaninaemia.

Authors:  A M Nord; L McCabe; E R McCabe
Journal:  J Inherit Metab Dis       Date:  1988       Impact factor: 4.982

2.  Effects of a high protein intake on renal acid excretion in bodybuilders.

Authors:  F Manz; T Remer; E Decher-Spliethoff; M Höhler; M Kersting; C Kunz; B Lausen
Journal:  Z Ernahrungswiss       Date:  1995-03

3.  Phenylketonuria: past, present, future. F. P. Hudson Memorial Lecture, Leeds, 1979.

Authors:  H Bickel
Journal:  J Inherit Metab Dis       Date:  1980       Impact factor: 4.982

4.  Retrospective approach to explain growth retardation and urolithiasis in a child with long-term nutritional acid loading.

Authors:  F Manz; H Schmidt
Journal:  Z Ernahrungswiss       Date:  1992-06

Review 5.  Advances in the nutritional and pharmacological management of phenylketonuria.

Authors:  Denise M Ney; Robert D Blank; Karen E Hansen
Journal:  Curr Opin Clin Nutr Metab Care       Date:  2014-01       Impact factor: 4.294

6.  Chronic kidney disease in adolescent and adult patients with phenylketonuria.

Authors:  Julia B Hennermann; Sylvia Roloff; Jutta Gellermann; Ilka Vollmer; Elke Windt; Barbara Vetter; Ursula Plöckinger; Eberhard Mönch; Uwe Querfeld
Journal:  J Inherit Metab Dis       Date:  2012-11-09       Impact factor: 4.982

7.  Glycomacropeptide for nutritional management of phenylketonuria: a randomized, controlled, crossover trial.

Authors:  Denise M Ney; Bridget M Stroup; Murray K Clayton; Sangita G Murali; Gregory M Rice; Frances Rohr; Harvey L Levy
Journal:  Am J Clin Nutr       Date:  2016-07-13       Impact factor: 7.045

8.  Amino Acid Medical Foods Provide a High Dietary Acid Load and Increase Urinary Excretion of Renal Net Acid, Calcium, and Magnesium Compared with Glycomacropeptide Medical Foods in Phenylketonuria.

Authors:  Bridget M Stroup; Emily A Sawin; Sangita G Murali; Neil Binkley; Karen E Hansen; Denise M Ney
Journal:  J Nutr Metab       Date:  2017-05-04

Review 9.  Protein Substitutes in PKU; Their Historical Evolution.

Authors:  Anne Daly; Sharon Evans; Alex Pinto; Catherine Ashmore; Anita MacDonald
Journal:  Nutrients       Date:  2021-02-02       Impact factor: 5.717

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.